First Duchenne Muscular Dystrophy Patient Dosed in Systemic Microdystrophin Gene Therapy – PR Newswire (press release)
|
First Duchenne Muscular Dystrophy Patient Dosed in Systemic Microdystrophin Gene Therapy
PR Newswire (press release) HACKENSACK, N.J., Jan. 17, 2018 /PRNewswire-USNewswire/ — Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced that the first Duchenne patient has been dosed with … |
